Laboratorios Farmaceuticos Rovi's total assets for Q1 2026 were €926.32M, a decrease of -3.07% from the previous quarter. ES:ROVI total liabilities were €239.58M for the fiscal quarter, a -13.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.